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Iatrogenic hypoglycemia as a result of hyperkalemia treatment is a common and 
potentially lethal complication.  People with renal impairment are at an increased risk for 
hyperkalemia and hypoglycemia due to a decrease in glomerular filtration rate. During 2017, 
there were 87 episodes of hypoglycemia associated with hyperkalemia treatment at The Queen’s 
Medical Center. The Academic Center for Excellence Star Model of Knowledge Transformation 
was used as the conceptual framework for the development of a standardized order set for 
providers and nurses that was implemented throughout The Queen’s Health Systems to reduce 
hypoglycemic episodes during hospitalization for hyperkalemia treatment.  
 The target population was patients admitted and treated for hyperkalemia with insulin 
and dextrose and the percentage that had a hypoglycemic event within six hours of insulin 
administration. Methods to evaluate outcomes were based on data reports and manual electronic 
medical record review and analysis. This new hyperkalemia order set replaced the current 
hyperkalemia order set in the EPIC/Care*Link systems and medication administration record, 
which included more efficient and timely blood glucose checks. The new order set was 
successfully implemented on October 06, 2018.   
Data was collected for two months, and during this period, 19 episodes of hypoglycemia 
were identified, and 14 treatments were implemented using the new order set.  In comparison to 
the 12 month data, the number of hypoglycemic episodes increased slightly from 17% to 22%.  
In the two-month data collection period, provider participation for computerized hyperkalemia 
order set entry increased by 11%, from 62% in calendar year 2017 to 73%.  Although, not a 
formal objective in this project, the time differences for blood glucose checks and identification 




noted.  Order set driven treatments that were used precisely and correctly as indicated in the 
revised protocol in the two months’ time frame showed efficient identification and treatments of 










Chronic Kidney Disease (CKD) continues to be an ongoing and prevalent issue in the 
United States affecting approximately 14% of the general population, often putting them at risk 
for multiple comorbidities, including electrolyte imbalances (National Institute of Diabetes and 
Digestive and Kidney Disease [NIDDKD], 2016). The kidneys are essential for the regulation of 
fluids, electrolytes, and acid-base balances.  A decrease in glomerular filtration rate (GFR) 
associated with CKD can cause disturbances in electrolytes including potassium, phosphate, 
magnesium, and sodium homeostasis (Dhondup & Qian, 2017).  An increase in potassium levels, 
or hyperkalemia, is one of the most dangerous electrolyte abnormalities, as it causes life 
threatening cardiac arrhythmias (Kovesdy, 2014).  Hyperkalemia is defined by the National 
Kidney Foundation (NKF) as serum potassium greater than 5.0 mEq/L (2017).  Current 
treatment for hyperkalemia includes the use of insulin plus glucose/dextrose to shift excess 
serum potassium intracellularly (Kovesdy, 2014).  The American Heart Association treatment 
guidelines includes an infusion mixture of 25 g of glucose and 10 units of insulin, infused over 
15 to 30 minutes for acute hyperkalemia treatment (Vanden Hoek et al., 2010). Although 
dextrose and insulin are the gold standard treatment of acute hyperkalemia, unfortunately, there 
are many reported incidences of hypoglycemia.  
 Hypoglycemia, defined as blood glucose (BG) below 70 mg/dL, is a common and 
sometimes lethal complication of hyperkalemia treatment.  This is primarily due to a decrease in 
renal clearance of insulin and reduction in gluconeogenesis (Apel, Reutrakul, & Baldwin, 2014; 
NIDDKD, 2016). In a retrospective study conducted in a large academic medical center 
emergency department in Chicago, Illinois, hypoglycemia occurred in 13.1 to 24.6% in patients 




treatment (LaRue, Peksa, & Shah, 2017).  If left untreated, hypoglycemia, can lead to neurogenic 
and neuroglycopenic symptoms (Service, Cryer, & Vella, 2017).  Neurogenic symptoms include 
pallor, tremors, palpitations, anxiety, diaphoresis, and paresthesia, while neuroglycopenic 
symptoms include psychomotor abnormalities, cognitive impairment, behavioral changes, 
seizures, coma, and even death (Service et al., 2017).   
Description of Problem/Need 
Currently, the hyperkalemia order set at The Queen’s Medical Center (QMC) includes 10 
units of regular insulin with IV bolus of 25-50 g of dextrose 50% (D50) (QMC, 2012).  Blood 
glucose checks are ordered every two hours (Q2H) for eight hours (QMC, 2012).  A 
retrospective chart review was conducted during a 12-month period (January-December 2017) 
with the following inclusion criteria: potassium level >5.0 mEq/L, administration of IV regular 
insulin, any degree of renal impairment, and a hypoglycemic event within six hours of insulin 
administration.  Within this time period, 503 occurrences of IV insulin administration with the 
sole intent to treat hyperkalemia were identified.  Of these 503 occurrences, 87 (17%) resulted in 
hypoglycemia, BG <70 mg/dL. Electronic Medical Records (EMR) were analyzed for 
electrophysiological changes associated with hyperkalemia, treatment for hyperkalemia, time 
from treatment to hypoglycemic episode, and BG values measured (with the focus on 
hypoglycemic episode value), and glomerular filtration rate (GFR).  Many of these cases were 
identified during transfer from the emergency room to a hospital unit.  GFR values for these 
patients ranged from 3-26 mL/min/1.73 m2, indicating severe decrease in kidney function for 81 
of the identified 87 patients.  Reported hypoglycemic symptoms included lethargy, dizziness, 
headache, shortness of breath, restlessness, and weakness. Average time from insulin to 




was also noted that providers were not ordering the current hyperkalemia order set, which 
contributed to the variability in treatment; out of 87 cases of hypoglycemia, only 54 (62%) were 
order set driven.  The other providers were ordering insulin and dextrose individually at their 
discretion.  The types of providers who treated these patients for hyperkalemia also varied, 
including: Emergency Department (ED) Physicians, Hospitalists, Anesthesiologists, Resident 
Physicians, Advance Practice Registered Nurses or Physician Assistants, Registered Nurses 
(RNs) who ordered for providers, and Surgeons.  Of the 54 providers who ordered the 
hyperkalemia order set, 37 were ED physicians. Non-protocol treated patients did not have 
prompt BG checks and the order set did not populate in their medication administration record 
(MAR). Patients were at a greater risk for hypoglycemia due to inadequate monitoring of 
potassium and glucose levels.  
Review of Literature 
A systematic literature search in PubMed, CINAHL, and Cochrane databases was 
conducted. Search terms included “Hyperkalemia”, “hyperkalemia treatment”, “management of 
hyperkalemia”, “renal impairment”, “renal insufficiency”, “acute kidney injury”, “AKI”, 
“CKD”, “chronic kidney diseases”, “ESRD”, “end stage renal disease”, “hypoglycemia”, 
“insulin”.  Search terms were searched individually and in conjunction using Boolean operators: 
“AND” and “OR”.  MeSH terms with subheadings were also used to refine the search.  The 
search was limited to 2005-2017 and resulted in 104 articles.  Articles were excluded if the 
abstract did not discuss glucose plus insulin for hyperkalemia treatment in patients with renal 
impairment.  Of the 104 articles, 18 articles met these inclusion criteria and were reviewed.  
Mosby’s Level of Evidence (LOE) was used to grade the evidence and assess internal validity 




A).  The category of “other” includes quality performance improvement, literature reviews, and 
clinical practice guidelines.  The overall quality and LOE was low and majority of the articles 
were graded level V or “other” consisting of retrospective reviews or descriptive studies, 
literature review articles, and two practice guidelines (Melnyk, 2011).  The synthesis resulted in 
two systematic reviews, one randomized cross-over double-blind study, one observational study, 
and two consensus statement articles.  Appendix C provides a summary of the articles reviewed 
and synthesized using Mosby’s LOE.  The validity of these articles was also assessed and ranged 
from fair to good.  All articles were judged to have no fatal flaws that invalidated the results and 
study design.  
Evidence Summary 
Hyperkalemia and Hyperkalemia protocol.  Indications for hyperkalemia treatment 
can have a starting range from 5.0 mEq/L and above (Chothia, Halperin, Rensburg, Hassan, & 
Davids, 2014; Kovesdy, 2014; Kovesdy, 2015; LaRue et al., 2017; Pierce et al., 2015).  In 
general, treatment for hyperkalemia included the administration of 10-20 units of insulin IV with 
50-100 ml of D50 bolus, equivalent to 25-50 g of glucose (Harel & Kamel, 2016).  However, the 
treatment of hyperkalemia varied by hospital institution and was at the attending providers’ 
discretion.   
Development of hypoglycemia.  Administration of 10 units of IV insulin with 25g of 
glucose as tested by Chothia et al. (2017) showed incidences of hypoglycemia which occurred 
within 60-90 minutes after insulin administration.  In studies with a hyperkalemia protocol with 
10 units of IV insulin with 25 g of glucose/dextrose, hypoglycemia developed at a median of two 
to three hours after insulin administration (Apel et al., 2014; Schafers, Naunheim, Vijayan, & 




Traditional insulin dosing.  An 8.7% to 13.0% risk of hypoglycemia in renal impaired 
patients was reported by Apel et al. (2014) and Schafers et al. (2011).  Hypoglycemia developed 
within a three-hour time window post-insulin administration, which should prompt close 
monitoring and BG measurements at baseline, one hour, and three hours post-insulin 
administration (Apel et al., 2014; Schafers, et al., 2011).   
Application to DNP project 
Based on the literature search and synthesis, there was a clear need for the development 
of a universal or standardized practice guideline for providers and nurses to use to reduce 
iatrogenic hypoglycemia. Although the literature review resulted in low LOE, it was clear that a 
modification to the current QMC hyperkalemia order set should include more frequent BG 
checks and administration of glucose in a timely and efficient manner.  
Conceptual Framework 
The Academic Center for Excellence (ACE) Star Model of Knowledge Transformation is 
the conceptual framework used for evidence-based practice (see Appendix B).  This model 
focuses on translating evidence into practice by highlighting appropriate forms of evidence, 
reducing the volume of literature, and directly applying into care and decision making (Stevens, 
2013).  The ACE Star Model of Knowledge Transformation was an appropriate choice for an 
Evidenced Based Practice (EBP) project because it focuses on implementing and applying EBP 
evidence and clinical expertise to develop clinical-practice guidelines or practices to improve 
quality in healthcare.   
PICO Question 
Based on the aforementioned background and problem, the following PICO statement 




acute hyperkalemia order set (I) reduce hypoglycemic episodes by 25%, defined as BG <70 
mg/dL (O) that is associated with hyperkalemia treatment in patients with renal impairment (P) 
compared to the current order set (C)?   
Purpose/Goals/Aims 
The purpose of this EBP was to reduce the incidence of hypoglycemia in patients treated 
with IV insulin for hyperkalemia across QMC’s four campuses (Punchbowl, West O`ahu, 
Molokai General Hospital, and North Hawai`i Community Hospital).  To achieve this, the 
current hyperkalemia order set was replaced with the new order set to include D50 IV push (IVP) 
accompanied by BG checks every one hour (Q1H) for three occurrences.  Once implemented, the 
goal was to reeducate providers about the existing order set and to review the revisions (new 
order set).  Once the order set was ordered by a provider, D50 IVP and BG checks for Q1H for 
three occurrences would automatically populate in the MAR.  In addition, nurses and ancillary 
staff were educated regarding the newly integrated hyperkalemia order set by checking blood 
glucose levels as indicated in the MAR.  Another goal of this Doctor of Nursing Practice (DNP) 
project was to increase provider participation by 50% and uniformity in hyperkalemia treatment 
by ordering and using this modified hyperkalemia order set. However, the primary objective was 
to decrease hypoglycemic episodes by 25% in patients treated for hyperkalemia using insulin and 
dextrose. 
Methods/Procedures 
EBP is a “problem solving approach to clinical decision making in a healthcare 
organization that integrates the best available scientific evidence with the best available 
experiential (patient and practitioner) evidence, considers internal and external influences on 




the individual patient, patient population, or system” (Dang & Dearholt, 2017, p. 4).  The use of 
EBP was appropriate for this project as it ensures that clinical expertise in addition to supported 
systematic research and evidence are in alignment with patient values.  The goal was to provide 
the best care for patients all the while upholding the bioethical principal of non-maleficence. 
Advantages of EBP include: improvement of patient outcomes and identification of opportunities 
for research, areas for improvement, and gaps in knowledge (Dang & Dearholt, 2017).   
Project Design 
Recommendations for change were indicated (see Appendix D and E) and based on 
recommendations from The QMC’s Nursing Practice Council, Diabetes Care Committee, and 
The Medicine and Nutrition Committee.  Appendix F outlines a simplified algorithm of 
interventions to prevent hypoglycemia which includes: immediate (STAT) BG check prior to 
insulin administration, blood glucose checks Q1H for three hours followed by glucose checks 
Q2H for four hours.  Parameters for D50 administration were outlined to alert the medical staff 
of declining trends in BG before the threshold of hypoglycemia occurs.   
 This project was approved for implementation in March 2018 and the process of integration 
of the revised order set with Informatics/Care*Link team into the EMR began in late March of 
2018.  The end date for this DNP project was December 06, 2018.  A Gantt chart shows the 
projected timeline (see Appendix G).  Approvals were received from the following QMC 
committees, as needed for implementation of new hyperkalemia order set: Diabetes Care 
Committee, Medicine and Nutrition Committee, and Nurse Practice Council.  A blueprint of the 
order set was also presented to the Care*Link team with the guidance of the nursing Informatics 
to ensure it will have the necessary components for EMR use.  The hyperkalemia order set was 




06, 2018.  Information sessions and in services were completed with the ED staff which included 
RNs and nursing assistants in five sessions over two weeks; attendance ranged from 15-20 staff 
members.  A presentation was done with ED providers and hospitalists prior to implementation, 
during the QMC’s ED Hale Meeting in September 2018.  In addition, the Information technology 
(IT) department also sent out a system wide bulletin notifying of the newly implemented order 
set.  After implementation of the new order set in the EMR, data collection on the following 
criteria began immediately: number of patients admitted to QMC for hyperkalemia who received 
treatment for hyperkalemia and number of patients who became hypoglycemic (blood glucose 
<70 mg/dL) within six hours post hyperkalemia treatment. A data analysis report was requested 
from the IT department containing data requested based on the parameters specified and 
compared to the baseline data from calendar year 2017.  Interpretation of the data report was 
done by manual EMR review.  
Evaluation/Results 
 EMR Data was captured and reviewed over two months from October 06-December 06, 
2018 (see Appendix H). During this time period, 87 occurrences of IV insulin administration for 
hyperkalemia treatment were identified. Of these 87 occurrences, 19 (22%) resulted in 
hypoglycemia. In terms of provider participation, all treatments were ordered by a physician (i.e., 
ED, resident, hospitalist), 14 (74%) of the 19 occurrences were order set driven and 5 (26%) of 
the 19 occurrences were based on individual provider orders.  The average time from insulin to 
hypoglycemia for all 19 episodes was 155  122 minutes. The average time from insulin 
administration to the first glucose check was 83  88 minutes.  Of 14 episodes that were order set 
driven, only five (36%) order sets were used correctly, precisely as indicated in the revised 




minutes, while the average times from insulin administration to the first glucose check were 58  
31 minutes for all 14 episodes and 53  24 minutes for five episodes that had correctly used 
order sets, respectively (see footnote in Appendix H). The five of 19 episodes that were not order 
set driven, resulted in an average time of 136  102 minutes from insulin administration to 
hypoglycemia and 152  152 minutes for the first glucose check after insulin administration. 
Limitations 
 A limitation of EBP for this project was the lack of available evidence or high LOE to meet 
the criteria of best available evidence. There was insufficient data regarding the prevalence of 
renal impairment and hypoglycemia that resulted from hyperkalemia treatment. In addition, no 
standard treatment protocol or algorithm for emergent acute hyperkalemia was identified.  There 
was also an insufficient number of articles appropriate for evidence-based practices as noted with 
Mosby’s Level I and II.  Majority of the articles reviewed consisted of retrospective studies and 
review articles, which does not accurately depict cause-and-effect following an intervention.  
 Limitations of this project design included retrospective data review from 2017 which did not 
account for any interventions or universal protocol for hyperkalemia.  In addition, 
implementation and integration of the revised hyperkalemia order including pre-intervention data 
collection and review took about 11 months. The order set could not be fully assimilated into the 
EMR without properly creating and programming it into the EMR system.  There were also a 
series of reviews of the order set done by the Informatics team, which required additional editing 
of the order set blueprints.  Instructions and in-service trainings on the new order set were 





Although the primary and secondary objectives were not formally met, there was 
potential for satisfaction of objectives if given a similar timeframe to the comparison group.  In 
comparison to the 12-month data, the number of hypoglycemic episodes increased slightly from 
17% to 22%.  Over only a two month data collection period, providers’ use of the computerized 
hyperkalemia order set entry increased by 11%, from 62% in calendar year 2017 to 73%.  
Although, not a formal objective in this project, the time differences observed between order set 
and non-order set driven treatment were noted.  Collectively, the average time from insulin to 
hypoglycemia increased from 146 minutes to 155 minutes when compared to year 2017.  When 
divided into subgroups, the average times from insulin to hypoglycemia for the 14 order set 
driven treatment, the five correctly used order set driven treatments and the give non-order set 
driven treatments, the times were 162 minutes, 97 minutes, and 136 minutes, respectively.  The 
average time from insulin administration and hypoglycemia were expected to decrease as 
glucose checks promoted efficient treatment for hypoglycemia.  Although, the time increased 
from the collective total and order set driven total, the five order sets that were used correctly 
showed a decrease of 49 minutes in average time when compared to 146 minutes in 2017.  
Collectively, the average time from insulin to the first glucose checked compared to year 2017 
decreased from 100 minutes to 83 minutes.  While the average time from insulin to the first 
glucose check for the 14 order set driven treatments was 58 minutes; the average time for the 
five correctly used order set driven treatments was 53 minutes; and the average time for the five 
non-order set driven treatments was 152 minutes, respectively.  The average time for the first 




for three occurrences. Data concluded that the average times decreased for all episodes related to 
the order set driven treatments when compared to non-order set driven treatments.  
 The use of the order set was also screened for completeness.  Only five of the 14 order 
sets were used as indicated from the modified provisions in the new order set; the remaining nine 
treatments did not complete the order set.  Reasons for incompleteness include: omitted Q1H 
blood glucose checks, missed Q1H checks at the third occurrence, opted-out of follow-up orders 
for dextrose and glucose checks, and missed administration of dextrose.  Providers had the 
option to opt-out of follow-up orders by unchecking a box in the EMR system, which includes 
dextrose administration orders and Q1H checks for three occurrences.   
This project had several barriers.  First, the integration of this new order set into the QHS 
EMR system required more time than expected.  As a result, only two months of data were 
collected for the results compared to the baseline data with 12 months.  Secondly, the sheer 
quantity of episodes in comparison to 2017 were also limited and may not reflect an accurate 
portrayal of the impact of this revised hyperkalemia order set.  Thirdly, the primary department 
that was targeted for this project was the emergency department.  This department was chosen 
strategically as majority of the hyperkalemia treatments were initiated in the ED.  Data was 
collected from all departments in the 12-months in 2017 and two months in 2018.  However, 
only the ED received formal training and educational sessions post-implementation of the new 
hyperkalemia order set.  Although, a system wide bulletin was sent to all staff notifying of the 
new order set, targeted interventions and educational sessions were not done for other 
departments.   
Facilitators of this project include communication, managerial and peer support, 




of this new hyperkalemia order set was possible with the guidance and views of various 
disciplines, which addressed potential obstacles from every level.  Communication between 
departments was also a key factor to ensure timely responses for the design and integration of the 
order set into the EMR.  Availability of data and reports were also dependent upon effective 
communication to ensure that the data and reports requested were precisely what was needed for 
data collection.  In addition, availability of time was integral to review patient records and the 
reports received.  
DNP Essentials  
The American Association of Colleges of Nursing created 8 Essentials listed in The 
Essentials of Doctoral Education for Advanced Nursing to “address the foundational 
competencies that are core to all advanced nursing practice roles” (American Association of 
Colleges of Nursing [AACN], 2006, p. 8).  The DNP degree focuses on “practice that is 
innovative and evidence-based, reflecting the application of credible research findings” (AACN, 
2006, p. 3). The following paragraphs will describe how this EBP project aligns and integrates 
with specific AACN essential competencies.    
 Essential I: Scientific Underpinnings for Practice.  This essential focuses on 
integrating extensive nursing science and knowledge to create a strong foundation congruent 
with nursing values and practice to improve health care delivery.  This project used knowledge 
from a several areas of expertise including: clinical practice guidelines, healthcare systems, 
research, and scientific principles to identify and develop a standardized protocol that could 
address the needs of an at-risk clinical population.   
 Essential II: Organizational and Systems Leadership.  This essential “emphasizes 




p. 10).  This DNP project attempted to assess the practice policies and strategies needed to 
balance productivity and quality of care to develop a sustainable hyperkalemia clinical set of 
orders at both the organizational and systems level.  In addition, cost-effectiveness and risks of 
this EBP project intervention were considered and implemented with realistic and effective 
designs and strategies.  Organizational, political, cultural, and economic perspectives were 
pertinent to ensure patient safety and quality of care upholding communication and 
collaboration.   
 Essential III: Clinical Scholarship and Analytical Methods for EBP.  The application 
of this competency focuses beyond research and scholarship and involves connecting and 
integrating knowledge, science, and human nature across disciplines and diverse sources. 
Clinical scholarship and analytical methods of EBP involves “translation of research into 
practice and the dissemination and integration of new knowledge” (AACN, 2006, p.11).  The 
primary goal of this DNP project focused on improving health outcomes of high risk patients.  
The revised hyperkalemia order set was created using the best available research and practice 
guidelines that was translated into practice while promoting safe, timely, efficient, equitable 
patient centered care (AACN, 2006, p.11).  
 Essential IV: Information Systems and Technology.  This essential highlight the use 
information systems and technology to improve patient care and systems.  Specifically, 
“information systems/technology provide a mechanism to apply budget and productivity tools, 
practice information systems and decision supports, and web-based learning or intervention tools 
to support” (AACN, 2006, p. 13).  This EBP project involved evaluating information systems 
and patient care technology to extract data, evaluate outcomes, provide leadership, and improve 




13).  Understanding the EMR of the organization and collaborating with the IT department was 
essential to creating and integrating a revised hyperkalemia order set into the EMR system.  In 
addition, data collection and analysis needed for pre and post interventions required proficiency 
and technical skills to evaluate data from the EMR and database.    
 Essential V: Health Care Policy for Advocacy in Healthcare.  Health care policy “is 
created through governmental actions, institutional decision making, or organizational standards-
-creates a framework that can facilitate or impede the delivery of health care services or the 
ability of the provider to engage in practice to address health care needs (AACN, 2006, p. 13).  
The development of the intervention for this EBP project needed to align with the organization’s 
policies and standards, including the mission and vision.  The organization’s policies and 
procedures were considered and followed to ensure development and implementation of the new 
order set was done professionally and appropriately. This project involved designing, executing 
and advocating a change in the internal health care policy to improve access to care, quality of 
care, and health care financing and to reduce health care disparities.   
 Essential VI: Interprofessional Collaboration. In order to fulfill the Institute of 
Medicine requirement “for safe, timely, effective, efficient, equitable, and patient-centered 
care in a complex environment, healthcare professionals must function as highly 
collaborative teams” (AACN, 2006, p. 14).  Effective communication and multi-disciplinary 
collaboration were consistently practice during this EBP project.  Collaboration with multi-
disciplinary roles including physicians, nurses, nursing assistants, IT support and 
interprofessional teams (i.e., Medicine and Nutrition Committee, Diabetes Care Committee, 
Informatics, and ER department staff) were necessary to develop and implement of newly 




 Essential VII: Clinical Prevention and Population Health.  Clinical prevention is 
defined as “health promotion and risk reduction/illness prevention for individuals and families. 
Population health is defined to include aggregate, community, environmental/occupational, and 
cultural/socioeconomic dimensions of health” (AACN, 2006, p. 15).  This project demonstrates 
clinical prevention and population health since the new hyperkalemia order set focuses on a 
population (i.e., patients with renal impairment, acute care/hospitalized patients) who are at risk 
for hyperkalemia and iatrogenic hypoglycemia.  The intervention from this EBP project 
addressed health promotion, health status, and potential gaps in care with a new standardized 
order set that will benefit the population who are at the most risk. 
 Essential VIII: Advanced Nursing Practice.  DNP programs provide the curriculum 
and foundational practices and skills needed to fulfill the growth of specialization in nursing.  
DNP graduates are “expected to demonstrate refined assessment skills and base practice on the 
application of biophysical, psychosocial, behavioral, sociopolitical, cultural, economic, and 
nursing science as appropriate in their area of specialization” (AACN, 2006, p. 16).  As 
previously aforementioned, an adverse effect of hyperkalemia treatment was hypoglycemia.  An 
adult-gerontology nurse practitioner with a diabetes educator certification with a specialize skills 
set to understand the complexities of potassium and glucose level management oversaw this 
project.  The adult-gerontology DNP student designed, implemented, and evaluated an 
intervention utilizing clinical judgement and evidence-based research, while developing 
therapeutic relationships with other professionals to improve patient outcomes and optimize care.  
Meetings and educational in services helped guide and support other nurses and groups through 





Plans for Dissemination 
The results will be shared through oral presentation and formal written report/publication. 
Results and feedback will be shared and gathered from staff members of the inpatient diabetes 
team and ED staff who were exposed and those who participated in the implementation of this 
new order set.    
Summary 
In summary, the five order sets that were used correctly and directly as indicated, 
although small, in the two months’ time frame showed efficient identification and treatments of 
hypoglycemia.  Future directions would be to continue to monitor the effects of the newly 
integrated hyperkalemia order set with the goal of reduction of hypoglycemia episodes.  Other 
potential directions would be to gather data and feedback regarding the new order set from 
providers and address concerns and suggestion for improvements to the order set.  It is also 
evident that more in services are needed to educate providers in other departments of the new 
order set and to understand reasonings of variations in orders and uses of the order set. Future 
implications would be to have this order set available to QHS system wide and potentially to 
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